Telaprevir Incivo 402957-28-2
1. Advanced Factory Building and Equipment
2. Competent technical team
3 .Strong R & D support
4,high quality products with high stability
5, Competitive price
5.Customer tailored service
Name: Telaprevir |
||
CAS No.: |
402957-28-2 |
|
Content: |
≥ 99.00% |
|
Appearance: |
A white,Crystalline Powder or colorless crystals |
|
Formula: |
C36H53N7O6 |
|
Molecular Weight |
679.85 |
|
Moisture: |
≤0.1% |
|
Loss on Drying: |
≤0.2% |
|
Residue on ignition: |
≤0.1% |
|
Heavy Metals: |
≤10PPM |
Telaprevir is a member of a class of antiviral drugs known as protease inhibitors used in the treatment of hepatitis C. Telaprevir is co-developed by Vertex Pharmaceuticals and Johnson & Johnson. Telaprevir has been formulated into tablet dosage form and marketed under the trade name of Incivek and Incivo.
On April 28, 2011, the FDA Antiviral Drugs Advisory Committee voted 18-0 to recommend approval telaprevir for people with genotype 1 chronic hepatitis C. Telaprevir was fully approved for use in the United States in May 2011.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View